Live Facebook chat on H1N1 flu

NewsGuard 100/100 Score

People who have questions about the H1N1 flu can get answers from infectious disease experts at Rush University Medical Center during a one-hour, live Facebook chat to be held on Friday, November 20 from12 p.m. until 1 p.m.

"Rush On-Call" will be the first information chat session hosted on the Rush University Medical Center Facebook page. Dr. James McAuley, director of pediatric infectious diseases, and Dr. Brian Harting, infectious disease expert, will answer questions that are posted on the wall of the hospital's Facebook.

"There is a lot of information out there about H1N1 and people still have questions," said McAuley. "We wanted to give parents, families, caregivers or anyone else who might have concerns about H1N1 direct access to experts so that they get the answers they are looking for."

Infectious disease experts will answer questions about H1N1 such as, who are the priority groups to get the vaccination, how many vaccinations are needed to protect against H1N1, what are the symptoms, where can people get vaccinated, and how safe is it to get vaccinated.

To participate in the live Facebook chat, visit
https://www.facebook.com/RushUniversityMedicalCenter and become a fan.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Promising influenza drug candidate shows activity against resistant variants